NCT07838363

Brief Summary

A focus groups study facilitating an open discussion regarding the experience of being assessed for an online Pain Management Programme (OPMP) during the Covid-19 Pandemic. The aim is to gain an understanding of patient decision making processes in relation to whether to attend an OPMP. and determining patient experiences of attending a OPMP during this time period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2024

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

September 3, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

September 24, 2026

Completed
Last Updated

September 24, 2026

Status Verified

September 1, 2026

Enrollment Period

2.3 years

First QC Date

September 3, 2026

Last Update Submit

September 23, 2026

Conditions

Pain Management

Keywords

Pain ManagementCovid-19Patient Experience

Outcome Measures

Primary Outcomes (1)

  • Determining patient decision making processes in relation to online PMP clinics

    Data will be collected via recordings of focus group discussions which will then be anonymously transcribed.

    Between 1-10 years following completion of WCFT pain management programme, dependant on randomly selected patient.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients from the Walton Centre NHS Foundation Trust who have attended an OPMP during the Covid-19 pandemic

You may qualify if:

  • Have attended a PMP assessment clinic and have been found clinically suitable for an online PMP at the Walton Centre
  • Consented to be contacted by the Walton Centre regarding potential involvement in research during the assessment process
  • Aged 18+
  • Able to provide written informed consent in English

You may not qualify if:

  • Individuals who are unable to understand the study protocol or are unable to provide informed consent independently

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Walton Centre NHS Foundation Trust

Liverpool, Merseyside, L97LJ, United Kingdom

Location

MeSH Terms

Conditions

AgnosiaCOVID-19

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Christian Ainsley

    Walton Centre NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2026

First Posted

September 24, 2026

Study Start

October 15, 2021

Primary Completion

February 2, 2024

Study Completion

February 2, 2024

Last Updated

September 24, 2026

Record last verified: 2026-09

Locations

GB(1)